Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Mol Genet Genomics ; 265(3): 543-51, 2001 May.
Article in English | MEDLINE | ID: mdl-11405638

ABSTRACT

Onion possesses organosulfur compounds and carbohydrates that provide unique flavor and health-enhancing characteristics. Significant phenotypic correlations have been reported among soluble solids content (SSC), total dry matter, pungency, and onion-induced in vitro antiplatelet activity. A genetic map and segregating F3M families derived from a cross between two inbred populations were used to identify and estimate the effects of quantitative trait loci (QTLs) controlling these traits at 30 and 90 days postharvest. In vitro antiplatelet activities among different onion populations were consistent across six human blood donors. Most of the populations showed in vitro antiplatelet activities; however, for some donors, one of the parental lines and two F3M families had pro-aggregatory effects under our experimental conditions. SSC, dry matter, pungency, and in vitro antiplatelet activity showed significant positive phenotypic and genetic correlations. A chromosome region on linkage group E accounted for a significant amount of the phenotypic variation for all of these traits. The correlations among these traits may be due to linkage or pleiotropy of genes controlling solids content. Our results indicate that it will be difficult to develop onion populations with lower pungency and high in vitro antiplatelet activity; however, the strong genetic and phenotypic correlations between high in vitro antiplatelet activity and high SSC are beneficial for the health functionality of onion.


Subject(s)
Genes, Plant , Onions/chemistry , Onions/genetics , Onions/therapeutic use , Phytotherapy , Taste , Adult , Chromosome Mapping , Female , Genetic Linkage , Genetic Variation , Genotype , Humans , Male , Middle Aged , Phenotype , Platelet Aggregation Inhibitors/pharmacology , Quantitative Trait, Heritable , Time Factors
2.
Article in English | MEDLINE | ID: mdl-11049697

ABSTRACT

We have shown previously that fresh garlic extract is effective in reducing thromboxane formation by platelets both in vivo and in vitro animal models of thrombosis. In the present study, the effect of different concentrations of a single dose of aqueous extracts of garlic and onion were evaluated on serum thromboxane-B(2)synthesis in rabbits. Different concentrations of garlic and onion were administered as single doses in the ear vein of rabbits. Rabbits were bled before and at different intervals after the infusion of garlic or onion extracts. Venous blood was collected and allowed to clot at 37 degrees C for 1 h. Thromboxane-B(2)level was measured in the serum by radioimmunoassay. It was observed that garlic inhibits the thrombin-induced platelet synthesis of TXB(2)in a dose-and time-dependent manner. Maximum inhibition of TXB(2)occurred between 0.5 h and 6 h at 25 and 100 mg kg(-1)garlic. At 24 h post-garlic infusion TXB(2)inhibition was reduced to 15% of the control and TXB(2)levels were comparable to that of the control values at 72 h pots-garlic infusion. Infusion of 100 mg kg(-1)onion extract did not elicit any inhibitory effect on TXB(2)synthesis in the serum of rabbit during the treatment period. The rapid recovery of platelet cyclooxygenase activity after infusion of a single dose of garlic suggests that garlic should be taken more frequently in order to achieve beneficial effects in the prevention of thrombosis.


Subject(s)
Garlic , Onions , Plant Extracts/administration & dosage , Plant Extracts/pharmacology , Plants, Medicinal , Thromboxane B2/blood , Animals , Antithrombins/administration & dosage , Antithrombins/pharmacology , Antithrombins/therapeutic use , Blood Coagulation , Blood Platelets/drug effects , Blood Platelets/enzymology , Blood Platelets/physiology , Dose-Response Relationship, Drug , Female , Garlic/therapeutic use , Injections, Intravenous , Onions/therapeutic use , Phytotherapy , Plant Extracts/therapeutic use , Platelet Aggregation Inhibitors/administration & dosage , Platelet Aggregation Inhibitors/pharmacology , Platelet Aggregation Inhibitors/therapeutic use , Prostaglandin-Endoperoxide Synthases/metabolism , Rabbits , Radioimmunoassay , Thrombosis/prevention & control , Time Factors
3.
Article in English | MEDLINE | ID: mdl-10883058

ABSTRACT

Antiplatelet actions of aqueous extract of onion were investigated in rat and human platelet. IC(50)values of onion extract for collagen-, thrombin-, arachidonic acid (AA)-induced aggregations and collagen-induced thromboxane A(2)(TXA(2)) formation were 0.17 +/- 0. 01, 0.23 + 0.03, 0.34 +/- 0.02 and 0.12 +/- 0.01 g/ml, respectively. [(3)H]-AA release induced by collagen (10 microg/ml) in rat platelet was decreased by onion compared to control (22.1 +/- 2.13 and 5.2 +/- 0.82% of total [(3)H]-AA incorporated, respectively). In fura-2 loaded platelets, the elevation of intracellular Ca(2+)concentration stimulated by collagen was inhibited by onion. Onion had no cytotoxic effect in platelet. Onion significantly inhibited TXA(2)synthase activity without influence on COX activity. Platelet aggregation induced by U46619, a stable TXA(2)mimetic, was inhibited by onion, indicating its antagonism for TXA(2)/PGH(2)receptor. These results suggest that the mechanism for antiplatelet effect of onion may, at least partly, involve AA release diminution, TXA(2)synthase inhibition and TXA(2)/PGH(2)receptor blockade.


Subject(s)
Onions/therapeutic use , Phytotherapy , Platelet Aggregation Inhibitors/pharmacology , 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid/pharmacology , Animals , Blood Platelets/drug effects , Blood Platelets/metabolism , Dose-Response Relationship, Drug , Humans , Inhibitory Concentration 50 , Plant Extracts/pharmacology , Platelet Aggregation/drug effects , Prostaglandin-Endoperoxide Synthases/drug effects , Prostaglandin-Endoperoxide Synthases/metabolism , Rats , Rats, Sprague-Dawley , Thromboxane A2/biosynthesis , Thromboxane B2/metabolism , Thromboxane-A Synthase/metabolism , Vasoconstrictor Agents/pharmacology
9.
Homeopathie ; 2(1): 5-12, jan.-fev. 1985.
Article in French | HomeoIndex Homeopathy | ID: hom-3293

ABSTRACT

A partir de sept observations, l'auteur justifie l'emploi des hautes dilutions dans les etats aigus, precise les regles d'application et cite les principaux medicaments qui lui ont paru, dans sa pratique, etre d'une reguliere fidelite, utilises en dilutions elevees


Subject(s)
Case Reports , Humans , Male , Female , Infant , Child , Adult , Middle Aged , Aged , High Potencies , Acute Disease , Aconitinum/therapeutic use , Onions/therapeutic use , Antimonium Tartaricum/therapeutic use , Arnica/therapeutic use , Eupatorium perfoliatum/therapeutic use , Arsenicum Album/therapeutic use , Atropa belladonna/therapeutic use , Cantharis vesicatoria/therapeutic use , Turpentine/therapeutic use , Colocynthis/therapeutic use , Dioscorea/therapeutic use , Chamomilla/therapeutic use , Cina maritima/therapeutic use , Solanum/therapeutic use , Mercurius Solubilis/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...